Jim Simons's position in Viridian Therapeutics is currently worth $3.38M. That's 0.00% of their equity portfolio (1584th largest holding). The first Viridian Therapeutics trade was made in Q1 2021. Since then Jim Simons bought shares six more times and sold shares on eight occasions. The investor's estimated purchase price is $6.22M, resulting in a loss of 46%.